Literature DB >> 19452480

Coronary flow slows as renal function worsens.

Mehmet Birhan Yilmaz1, Kenan Yalta.   

Abstract

BACKGROUND: Slow coronary flow in patients without obstructive coronary artery disease is an angiographic finding that could easily be detected by thrombolysis in myocardial infarction (TIMI) frame counts. On the other hand, impaired renal function is a frequent problem. We searched the association between the 2 entities. HYPOTHESIS: We evaluated the impact of impaired renal function on slow coronary flow.
METHODS: In this study, 105 patients with normal coronary arteries and impaired renal function in the form of a calculated glomerular filtration rate (GFR) < 90 mL/min/1.73 m(2) were enrolled and compared with 102 age- and sex-matched controls who had normal a GFR.
RESULTS: Calculated GFR was found to be negatively correlated with TIMI frame count in LAD (r = - 0.579, p < 0.001), in CX (r = - 0.499, p < 0.001), and in RCA (r = - 0.491, p < 0.001) in patients with impaired renal function. After adjusting for systolic and diastolic blood pressure and high-density lipoprotein (HDL) cholesterol, multiple regression analysis demonstrated a statistically significant and independent relationship between TIMI frame count for 3 vessels and calculated GFR.
CONCLUSIONS: Impaired renal function seems to denote slower coronary flow in patients with normal coronary arteries compared with those with normal renal function, and there seems to be an independent association between GFR and TIMI frame count in those with impaired renal function. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19452480      PMCID: PMC6653305          DOI: 10.1002/clc.20387

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  6 in total

1.  Transient no reflow following primary percutaneous coronary intervention.

Authors:  Hiroyuki Jinnouchi; Kenichi Sakakura; Hiroshi Wada; Kenshiro Arao; Norifumi Kubo; Yoshitaka Sugawara; Hiroshi Funayama; Shin-ichi Momomura; Junya Ako
Journal:  Heart Vessels       Date:  2013-06-27       Impact factor: 2.037

Review 2.  Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence.

Authors:  Daniel S Feuer; Eileen M Handberg; Borna Mehrad; Janet Wei; C Noel Bairey Merz; Carl J Pepine; Ellen C Keeley
Journal:  Am J Med       Date:  2022-04-23       Impact factor: 5.928

3.  Quantitative flow ratio and fractional flow reserve mismatch - clinical and biochemical predictors of measurement discrepancy.

Authors:  Martyna Zaleska; Lukasz Koltowski; Jakub Maksym; Aleksandra K Chabior; Aleksandra Pohadajło; Mateusz Soliński; Mariusz Tomaniak; Grzegorz Opolski; Janusz Kochman
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-09-18       Impact factor: 1.426

4.  Fragmented QRS Pattern in Patients with COVID-19: Further Insights into Its Temporal and Mechanistic Features.

Authors:  Gökay Taylan; Cihan Öztürk; Kenan Yalta
Journal:  Anatol J Cardiol       Date:  2022-03       Impact factor: 1.475

5.  Pheochromocytoma and Takotsubo Syndrome: An Ominous Duo.

Authors:  Kenan Yalta; Tülin Yalta; Ertan Yetkin
Journal:  Anatol J Cardiol       Date:  2022-08       Impact factor: 1.475

6.  Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts.

Authors:  Mohammad Hashemi-Jazi; Sayed Mojtaba Hosseini; Ali Gholamrezaei
Journal:  ARYA Atheroscler       Date:  2017-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.